$35.27
$0.04
(0.11%)
Quote as of 1:01 PM EST on 02/15/12
Charles River Laboratories
NYSE:CRL
|
$35.27
$0.04
(0.11%)
|
|
| Today's Open | $35.33 |
|---|---|
| Previous Close | $35.23 |
| Daily Range | $34.67 - $35.63 |
| 52-Week Range | $25.52 - $42.84 |
| Market Cap | $1.74B |
| P/E Ratio | 13.76 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 447,522 |
| Average Daily Volume | 629,214 |
| Current FY EPS | $2.43 |
CRL Information
| Description |
|---|
| Charles River supports early-stage drug development with a “research models” business that breeds lab rats and “preclinical services” that run clinical trials for pharma and biotech companies. |
| Sector |
| Healthcare |
| Industry |
| Life Sciences Tools and Services |
News & Commentary
US STOCK FUTURES: HOT STOCKS TO WATCH
US STOCK FUTURES: HOT STOCKS TO WATCH
Upgrades & Downgrades: Nobody Doesn't Like Sara Lee
Update on VPHM's Industrial Facility - Analyst Blog
Novo Nordisk Posts Solid 4Q - Analyst Blog
Why Drug Development Company Charles River Laboratories Is Undervalued
Why Charles River Laboratories International May Be About to Take Off
MannKind Treads the Neutral Path - Analyst Blog
Bristol-Myers/AstraZeneca get CRL - Analyst Blog
Company News for January 11, 2012 - Corporate Summary
